Ribavirin aerosol approved for severe cases of RSV in infants and young children

FDA Drug Bull. 1986 Jun;16(1):7.
No abstract available

MeSH terms

  • Aerosols
  • Child, Preschool
  • Humans
  • Infant
  • Mutagens
  • Respiratory Syncytial Viruses
  • Respirovirus Infections / drug therapy*
  • Ribavirin / administration & dosage*
  • Ribavirin / adverse effects
  • Ribonucleosides / administration & dosage*
  • Teratogens
  • United States
  • United States Food and Drug Administration

Substances

  • Aerosols
  • Mutagens
  • Ribonucleosides
  • Teratogens
  • Ribavirin